Isolation Protocols for Mitigate Influenza in Children

Abstract

Objective: Influenza, which is characterized by febrile nature and acute respiratory manifestations, poses a significant threat to children with respect to morbidity and mortality. This study aimed to assess influenza infection data among children during periods of enforced isolation and subsequently when these measures were lifted. Methods: This retrospective cross-sectional study categorized patients into two groups: i) influenza direct fluorescent antibody test (DFT) positive patients admitted between June 16, 2021 and June 15, 2022, when isolation measures were in effect (Group 1) and ii) influenza DFT-positive patients admitted between June 16, 2022 and June 15, 2023, when isolation measures were lifted (Group 2). Results: Influenza A was predominant in Group 1, whereas influenza A and B were more evenly distributed in Group 2, demonstrating a statistically significant difference (p<0.001). The incidence of moderate-to-severe disease was significantly higher in Group 2 than in Group 1 (p<0.001). Groups 1 and 2 differed significantly in terms of hospitalization duration and clinical recovery time (5 [1–7] days vs. 7 [3–9] days, **P<0.001 and 3 [1–4] days vs. 5 [4–7] days, p<0.001, respectively). The analysis of monthly infection distribution revealed a peak occurring 3 months earlier in Group 2 than in Group 1. In Group 1, compliance rates to vaccination recommendations by physicians and pediatricians were 33% and 58%, respectively, whereas compliance rates in Group 2 were 31.5% and 43.7%, respectively. Conclusions: Implementing basic measures such as hand hygiene and mask-wearing can mitigate viral outbreaks. Elevating the rate of physician recommended vaccinations can potentially alleviate disease burden and mitigate disease severity.

Keywords

• Oseltamivir
• Influenza
• Isolation
• Vaccine
• SARS-CoV-2

References

1. American Academy of Pediatrics. Influenza. In: Red Book: 20212024 Report of the Committee on Infectious Diseases, 32nd ed. Kimberlin, D.W., Barnett, E.D., Lynfield, R., Sawyer, M.H. (Eds), American Academy of Pediatrics, Itasca. 2021. google scholar
2. World Health Organization. Influenza (Seasonal). Available online: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) (accessed on October 10, 2024. google scholar
3. Committee On Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2022-2023. Pediatrics. 2023; 150. doi: 10.1542/peds.2022-059274. google scholar
4. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014; 348:g2545. doi: 10.1136/bmj.g2545. google scholar
5. Nelson CA, Meaney-Delman D, Fleck-Derderian S, Cooley KM, Yu PA, Mead PS, et al. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response. MMWR Recomm Rep. 2021; 70:1. doi: 10.15585/mmwr.rr7003a1. google scholar
6. Peaper, D.R., Landry, M.L. Rapid diagnosis of influenza: state of the art. Clin Lab Med. 2014 Jun;34(2):365-85. doi: 10.1016/j. cll.2014.02.009. google scholar
7. Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis. Ann Intern Med. 2017 Sep 19;167(6):394-409. doi: 10.7326/M17-0848. google scholar
8. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B Virus Infections in Children. Clinical Infectious Diseases. 2023; 36(3):299—305. doi: 10.1086/345909. google scholar

9. Ip DKM, Lau LLH, Chan KH, et al. The Dynamic Relationship Between Clinical Symptomatology and Viral Shedding in Naturally Acquired Seasonal and Pandemic Influenza Virus Infections. Clin Infect Dis. 2016; 15;62(4):431-437. doi: 10.1093/cid/civ909. google scholar
10. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T. Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J. 2009; 28:372. doi: 10.1097/ INF.0b013e318191eef7. google scholar
11. Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P et al. Clinical Presentation of Influenza in Children Aged 6-35 Months: Findings from a Randomized Clinical Trial of the Inactivated Quadrivalent Influenza Vaccine. Pediatr Infect Dis J. 2019; 38:866. doi: 10.1097/INF.0000000000002387. google scholar
12. Antoon JW, Hall M, Herndon A, Johnson DP, Brown CM, Browning WL, et al. Prevalence, Risk Factors, and outcomes of influenza-associated neurological complications in children. J Pediatr. 2021; 239:32. doi: 10.1016/j.jpeds.2021.06.075. google scholar
13. Hu JJ, Kao CL, Lee PI, Chen CM, Lee CY, Lu CY, et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect. 2004; 37:95. google scholar
14. Jules A, Grijalva CG, Zhu Y, Talbot HK, Williams JV, Poehling KA, et al. Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. Pediatrics. 2015; 135:e66. doi: 10.1542/ peds.2014-1168. google scholar
15. Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. Changes in Influenza and Other Respiratory Virus Activities During the COVID-19 Pandemic in the United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021; 70(29):1013-19. doi: 10.15585/ mmwr.mm7029a1. google scholar
16. Haeder SF. Assessing parental intention to vaccinate for COVID-19, influenza, and RSV in the United States in late 2023. Vaccine. 2023; 41(50):7503-14. doi: 10.1016/j.vaccine.2023.11.004. google scholar
17. Kamidani S, Garg S, Rolfes MA, Campbell AP, Cummings CN, Haston JC, et al. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic. Clin Infect Dis. 2022; 75:1930. doi: 10.1093/cid/ciac296. google scholar
18. Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022; 399(10334):1463-1464. doi: 10.1016/S0140-6736(22)00383-X. google scholar
19. B. Cong, S. Deng, X. Wang, Y. Li. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19: A systematic review and meta-analysis. J Glob Health. 2022; 12:05040. doi: 10.7189/jogh.12.05040. google scholar
20. Centers for Disease Control and Prevention. Influenza (Flu). 2023. Available at Accessed October 05, 2024. google scholar
21. Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L et al. Efficacy of oseltamivir treatment within 5 days of symptom onset for reducing influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomized placebo-controlled trial. Lancet Infect Dis. 2014; 14:109. doi: 10.1016/ S1473-3099(13)70267-6. google scholar
22. T.C. Sağlık Bakanlığı Halk, Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. 2021-2022 Haftalık İnfluenza Raporları. Available at Accessed October 10, 2024. google scholar
23. T.C. Sağlık Bakanlığı Halk, Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar ve Erken Uyarı Dairesi Başkanlığı. 2022-2023 Haftalık İnfluenza Raporları. Available at Accessed October 10, 2024. google scholar